SCHEMBL7083574

SCHEMBL7083574

CCCCCC(=O)n1cccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.48
TDP1 Q9NUW8 3/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
CES2 O00748 4/20 0.46
CES1 P23141 4/20 0.46
AKR1B1 P15121 1/20 0.44
GPR84 Q9NQS5 7/20 0.43
PPARG P37231 7/20 0.43
PPARD Q03181 7/20 0.43
PPARA Q07869 7/20 0.43
HDAC11 Q96DB2 5/20 0.43
TSHR P16473 4/20 0.43
PTPN1 P18031 3/20 0.43
ALDH1A1 P00352 2/20 0.43
TLR2 O60603 2/20 0.43
FABP4 P15090 2/20 0.43
SLC22A6 Q4U2R8 1/20 0.43
SLC22A8 Q8TCC7 1/20 0.43
ESR1 P03372 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28170615 0.98 CES2 (0.48) L3MBTL1TDP1MEN1KMT2ACES2
SCHEMBL9013815 0.79 CES2 (0.54) TDP1MEN1KMT2ACES2CES1
SCHEMBL13725818 0.76 HSD17B3 (0.40) L3MBTL1TDP1MEN1KMT2ACES2
SCHEMBL5579728 0.74 TBXAS1 (0.47) L3MBTL1TDP1MEN1KMT2ACES2
SCHEMBL2944337 0.74 TBXAS1 (0.47) L3MBTL1TDP1MEN1KMT2ACES2
SCHEMBL5966050 0.74 TBXAS1 (0.47) L3MBTL1TDP1MEN1KMT2ACES2
SCHEMBL20078981 0.74 TBXAS1 (0.47) L3MBTL1TDP1MEN1KMT2ACES2
SCHEMBL5580017 0.74 TBXAS1 (0.47) L3MBTL1TDP1MEN1KMT2ACES2
SCHEMBL12661128 0.72 MEN1 (0.47) L3MBTL1TDP1MEN1KMT2ACES2
Benzene SCHEMBL28358854 0.69 KMT2A (0.73) TDP1MEN1KMT2ACES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104069123-B Xanthurenic acid (4,8-Er Qiangjikuilinjiasuan) derivatives medicinal composition and correlation technique thereof 纳图龙公司 2016-10-05 CN disclosed
EP-1154996-B1 AROYL AMINOACYL PYRROLES FOR USE IN THE TREATMENT OF NEUROPATHIC PAIN ORTHO MCNEIL PHARM INC (US) 2003-11-05 EP disclosed
US-6369228-B2 ANTICONVULSANTS ORTHO-MCNEIL PHARMACEUTICAL, INC. 2002-04-09 US disclosed
US-20010044452-A1 Aroyl aminoacyl pyrroles for use in the treatment of neuropathic pain CARSON JOHN R (US) 2001-11-22 US disclosed
EP-1154996-A2 AROYL AMINOACYL PYRROLES FOR USE IN THE TREATMENT OF NEUROPATHIC PAIN Ortho-McNeil Pharmaceutical, Inc. (US) 2001-11-21 EP disclosed
US-6191142-B1 Aroyl aminoacyl pyrroles for use in the treatment of neuropathic pain ORTHO-MCNEIL PHARMACEUTICAL, INC. 2001-02-20 US disclosed
WO-2000048584-A2 AROYL AMINOACYL PYRROLES FOR USE IN THE TREATMENT OF NEUROPATHIC PAIN ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2000-08-24 WO disclosed
US-5332736-A Anti-convulsant aroyl aminoacylpyrroles ORTHO PHARMACEUTICAL CORPORATION (US) 1994-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010044452-A1 Aroyl aminoacyl pyrroles for use in the treatment of neuropathic pain OPRL1, AADAT, OPRK1 L3MBTL1 4145/4885TDP1 2114/4885MEN1 4820/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.